Emilya Huseynova/LinkedIn
Oct 22, 2025, 08:36
Emilya Huseynova to Speak at AABB 2025
Emilya Huseynova, Principal Scientist in Clinical Research at The American Red Cross, shared on LinkedIn:
”Make plans to see me at AABB 2025!
I’m thrilled to share that I am a speaker at the Annual Meeting of the Association for the Advancement of Blood and Biotherapies, taking place Oct 25-28, in San Diego, CA.
Join me for the Plenary Abstract session from 10:00-11:30am on Sun, Oct 26 to learn more about blood safety in a changing environment and explore how we can improve it together.
Find out more about the AABB Annual Meeting here.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?
-
Sep 30, 2026, 13:03Amira Mohy: Diagnostic Flow Cytometry Panels for Hematological Malignancies